Furthermore, KIR2DL4 was found to be highly expressed in melanoma and contribute to the immunotherapy effect and prognosis in patients with melanoma via activating the immune cells such as NK cells and T cells [27]. The gene discussed is KIR2DL4; the disease is melanoma.